论文部分内容阅读
2007年7月4日,作为PEPCADⅢ临床试验的一部分,第一例Coroflex DEBlue由Bruno Scheller医生在Saarland大学医院置入。PEPCAD III是欧洲多中心随机临床试验,计划入组患者600例,以比较Coroflex DEBlue和Cypher支架治疗复杂原发病变的结果。Coroflex DEBlue是世界上第一个药物洗脱
July 4, 2007 As part of the PEPCAD III clinical trial, the first Coroflex DEBlue was placed at Saarland University Hospital by Dr. Bruno Scheller. PEPCAD III is a European multicenter randomized clinical trial involving 600 patients enrolled to compare Coroflex DEBlue and Cypher stents in the treatment of complex primary lesions. Coroflex DEBlue is the world’s first drug to elute